Gerhard Mueller,
Senior Vice President,
Mercachem BV
PhD in Organic Chemistry, Technical University of Munich, group of Prof. Kessler 1992-1994 Glaxo Verona 1994-2001 Bayer AG, Leverkusen 2001-2003 Organon, Netherlands, Section Head Lead Finding 2003-2005 CSO at Axxima Pharmaceuticals 2005-2008 VP Drug Discovery at GPC Biotech AG 2008-2011 CSO Proteros Fragments Since beg 2011: Senior Vice President Med Chem at Mercachem
Novel Target Family-Centric Scaffolded Libraries Applying the Privileged Structure Concept: Unlocking the Kinase, PDE, GPCR, and Epigenetic Target Space
Wednesday, 14 March 2012 at 10:00
Add to Calendar ▼2012-03-14 10:00:002012-03-14 11:00:00Europe/LondonNovel Target Family-Centric Scaffolded Libraries Applying the Privileged Structure Concept: Unlocking the Kinase, PDE, GPCR, and Epigenetic Target SpaceSELECTBIOenquiries@selectbiosciences.com
Novel privileged structure concepts are introduced to unlock the therapeutic value of most relevant target families, such as PDEs, GPCRs, kinases and epigenetic targets.
Add to Calendar ▼2012-03-13 00:00:002012-03-14 00:00:00Europe/LondonStructural and Computational ChemistrySELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2012-03-14 10:00:002012-03-14 11:00:00Europe/LondonNovel Target Family-Centric Scaffolded Libraries Applying the Privileged Structure Concept: Unlocking the Kinase, PDE, GPCR, and Epigenetic Target SpaceSELECTBIOenquiries@selectbiosciences.com
